ONCOSIGNATURE Trademark

[ Pharmaceutical preparations for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; medical preparations for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; veterinary pharmaceutical preparations for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; pharmaceutical and medical preparations for treatment, prevention and alleviation of cancer; pharmaceutical and medical preparations for the prediction of drug treatment efficacy; pharmaceutical and medical preparations for prognosis related to cancer; biological preparations for medical and veterinary purposes, namely, for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing, specifically in oncology and premalignant disorders and benign tumors; chemical preparations for therapeutic use, namely, for pharmaceutical or medical purposes, namely, for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; reagents for medical use, namely, for medical diagnosis, drug-tailored efficacy prediction and/or analysis; clinical medical reagents; diagnostic preparations for medical and veterinary purposes; diagnostic test materials for medical use in the field of oncology in the form of a clinical biomarker signature assay on biopsy or other patient sample material for measuring biomarkers reflective of disease-driving processes that the drug inhibits and does not inhibit to predict treatment efficacy within oncology; diagnostic preparations for medical use; diagnostic biomarker reagents for medical purposes; companion diagnostic biomarker reagents for medical purposes ]

[ Scientific and ] technological research and consultation services, namely, in the medical * and pharmaceutical research fields of drug-tailored, efficacy-predictive biomarkers, pharmacodynamic biomarkers, patient responder identification, and indication finding * [ pharmaceutical, and scientific research fields of drug-tailored, efficacy-predictive biomarkers, pharmacodynamic biomarkers, drug repurposing, and identification of rational drug combinations ] ; industrial analysis and research services, namely, industrial research in the field of oncology * biomarkers and predictive modeling; * basic medical research and medical clinical research, hereunder for development of therapeutics * using biomarkers and predictive modeling; * drug discovery services * in the medical and pharmaceutical research fields of drug-tailored efficacy-predictive biomarkers, patient responder identification, pharmacodynamic biomarkers and indication finding; * consultancy in the field of pharmaceutical research and development * services in the medical and pharmaceutical research fields of drug-tailored efficacy-predictive biomarkers, patient responder identification, pharmacodynamic biomarkers and indication finding; * medical and scientific research related to cancer and cancer therapy, including research related to treatment, prevention and alleviation of cancer * in the medical and pharmaceutical research fields of drug-tailored efficacy-predictive biomarks, patient responder identification, pharmacodynamic biomarkers and indication finding; * pharmaceutical research services related to prediction of drug treatment efficacy * using biomarkers and predictive modeling; * medical research services related to cancer diagnosis, cancer prognosis and drug-tailored efficacy prediction * using biomarkers and predictive modeling; * medical research, namely, analysis related to cancer diagnosis, cancer prognosis and drug-tailored efficacy prediction * using biomarkers and predictive modeling *